» Articles » PMID: 34650947

COVID-19: Pulmonary and Extra Pulmonary Manifestations

Overview
Specialty Public Health
Date 2021 Oct 15
PMID 34650947
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

The coronavirus disease-2019 (COVID-19) pandemic has been the most significant event in 2020, with ~86.8 million cases and 1.88 million deaths worldwide. It is a highly infectious disease, wherein the virus (severe acute respiratory syndrome coronavirus 2) rapidly multiplies and spreads to all parts of the body. Therefore, COVID-19 is not only respiratory disease but also a multisystem disease. Many people, including physicians, incorrectly believe that the disease affects only the respiratory tract. In this study, we aimed to describe COVID-19 manifestations and the underlying pathophysiology to provide the readers with a better understanding of this disease to achieve good management and to control the spread of this disease. Secondary data were obtained from PubMed, Google Scholar, and Scopus databases. The keywords used for the search were as follows: COVID-19, COVID-19 pulmonary manifestations, COVID-19 extra pulmonary manifestations, and pathophysiology of COVID-19. We collected secondary data from systemic reviews, metaanalyses, case series, and case reports in the form of public data that was published on websites of the government, medical corporations, medical peer-reviewed journals, and medical academies, all of which were indexed in PubMed, Google Scholar, or Scopus. Our questions were as follows: Is COVID-19 a respiratory disease only? and What are the extrapulmonary manifestations of COVID-19? From our data, we found that a patient with COVID-19 may be either asymptomatic or symptomatic. Symptomatic cases may have either pulmonary or extrapulmonary manifestations. Pulmonary manifestations occur as mild, moderate, or severe cases. In mild and moderate cases, extrapulmonary manifestations such as gastroenteritis, fever, or vomiting may present alone. Some of these cases may be missed for diagnosis, and the patient may receive symptomatic treatment without a COVID-19 diagnosis, leading to increased spread of the infection. Extrapulmonary manifestations may occur in severe and critical cases as complications of severe infections (high viral overload) or the cytokine storm, such as in acute kidney injury (AKI), heart failure (HF), and venous thromboembolic (VTE) manifestation. COVID-19 is not a respiratory disease alone; rather, it is a multisystem disease. Pulmonary and extrapulmonary manifestations should be considered for early diagnosis and to control the spread of the infection.

Citing Articles

Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection.

Shu Y, Huang J, Zhang Y, Wang F, Wang X, Meng L BMC Nephrol. 2025; 26(1):71.

PMID: 39934691 PMC: 11817977. DOI: 10.1186/s12882-025-04000-x.


High Rate of Thromboembolic Events in the Last Year of Life of Cancer Patients: A Registry Study.

Strang P, Schultz T Cancers (Basel). 2024; 16(23).

PMID: 39682217 PMC: 11640034. DOI: 10.3390/cancers16234031.


Clinical Maternal and Neonatal Features in COVID-19 Infected Pregnancies in Tianjin, China.

Liu Y, Li S, Liu R Int J Gen Med. 2024; 17:6075-6087.

PMID: 39678687 PMC: 11646384. DOI: 10.2147/IJGM.S488808.


A Retrospective Data Audit of Outcome of Moderate and Severe Covid-19 Patients Who Had Received MP and Dex: A Single Center Study.

Li Y, Dong C, Xing Y, Ma X, Ma Z, Zhang L Infect Drug Resist. 2024; 17:5491-5505.

PMID: 39676848 PMC: 11639968. DOI: 10.2147/IDR.S418788.


COVID-19: a multi-organ perspective.

Guarienti F, Goncalves J, Budelon Goncalves J, Xavier F, Marinowic D, Machado D Front Cell Infect Microbiol. 2024; 14:1425547.

PMID: 39492990 PMC: 11527788. DOI: 10.3389/fcimb.2024.1425547.


References
1.
Jordan R, Adab P, Cheng K . Covid-19: risk factors for severe disease and death. BMJ. 2020; 368:m1198. DOI: 10.1136/bmj.m1198. View

2.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

3.
Vindegaard N, Benros M . COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020; 89:531-542. PMC: 7260522. DOI: 10.1016/j.bbi.2020.05.048. View

4.
Wei C, Liu Y, Liu Y, Zhang K, Su D, Zhong M . Clinical characteristics and manifestations in older patients with COVID-19. BMC Geriatr. 2020; 20(1):395. PMC: 7542569. DOI: 10.1186/s12877-020-01811-5. View

5.
Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View